跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bavencio - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bavencio
Approved
STANDARD
Bavencio
Merck Serono SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
aa50666fbbee315e
Company
Merck Serono SA
Type
Standard
Approval Details
Approval Id
aa50666fbbee315e
Drug Approval Philippines Name
Bavencio
Product Name
Bavencio
Registration Number
BR-1467
Brand Name
Bavencio
Generic Name
Avelumab
Dosage Form
Concentrate for Solution for Infusion (IV)
Dosage Strength
200 mg/10 mL (20 mg/mL)
Manufacturer
Merck Serono SA
Importer
Merck, Inc.
Distributor
Merck, Inc.
Company Detail Path
/organization/merck-serono-sa
Importer Detail Path
/organization/merck-inc
Distributor Detail Path
/organization/merck-inc
Issuance Date
22 February 2024
Expiry Date
22 February 2029
Pharmacologic Category
Monoclonal Antibodies
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
aa50666fbbee315e
Type
Standard
Back to Philippines FDA Approvals